PREFERABLE_II

36 posts

PREFERABLE_II banner
PREFERABLE_II

PREFERABLE_II

@PREFERABLE_II

#HorizonEU funded project on Personalised Exercise-Oncology for improvement of supportive cancer care

Utrecht, Nederland Katılım Ocak 2023
40 Takip Edilen83 Takipçiler
PREFERABLE_II retweetledi
Anne May
Anne May@annemariamay·
🙏 to @Europadonna for participating in @preferable_mbc & representing the patients' perspective. It was a pleasure working and continue working with you. I also thank the European Commissioner @SKyriakidesEU for her video message on PREFERABLE's results: vimeo.com/980735575
Anne May tweet media
Europa Donna@EuropaDonnaEUR

➡️ On 29/06, ED board member Ximena Montano, Exec. Dir. @MarziaZambon & Policy Officer Martina Fontana attended the @PREFERABLE_MBC Project symposium. The final results show that supervised exercise programs significantly improve QoL for MBC patients. 🔗 bit.ly/4eZkEv5

English
0
3
18
1K
PREFERABLE_II
PREFERABLE_II@PREFERABLE_II·
The PREFERABLE II Consortium was well represented during the #ISEO pre-conference at #ACSM24. @annemariamay presented the PREFERABLE studies as example of successful multinational exercise oncology RCTs, showing that teamwork makes the dream work.
PREFERABLE_II tweet media
English
0
7
21
1.5K
PREFERABLE_II retweetledi
Moritz Schumann
Moritz Schumann@Moritz_Schumann·
A great morning in Boston at the planning meeting of the International Society of Exercise Oncology #ISEO. Also great to see @annemariamay presenting the preferable consortium as an excellent example for multi center international trials. @PREFERABLE_MBC @PREFERABLE_II
Moritz Schumann tweet media
English
0
4
15
966
PREFERABLE_II
PREFERABLE_II@PREFERABLE_II·
During our 4th consortium meeting in Stockholm, we discussed the progression of our clinical trial (LION-RCT), survey and focus groups (LION-COM and ELSI) at each site. We are happy to announce that the first center (UMCU) has started inclusions for the clinical trial! #HorizonEU
PREFERABLE_II tweet media
English
2
5
10
1.7K
PREFERABLE_II
PREFERABLE_II@PREFERABLE_II·
Informing all Dutch oncologists about the positive effects of exercise as strategy to prevent cancer, improve prognosis & reduce side effects during and after treatment & the LION study, which is about to start recruitment. @annemariamay @AnoukHiensch @HorizonEU #oncologiedagen
PREFERABLE_II tweet media
English
0
0
6
159
PREFERABLE_II
PREFERABLE_II@PREFERABLE_II·
🗣️Ben jij afgelopen jaar behandeld voor kanker en heb je interesse in deelname aan een focusgroep? Ga in gesprek over online beweegprogramma’s na de behandeling van kanker. Interesse? Meer informatie en aanmelden kan hier: lnkd.in/ez-jXk3G @NFKkanker @borstkanker @hetAVL
Nederlands
0
2
1
232
PREFERABLE_II retweetledi
Anne May
Anne May@annemariamay·
EU Science & Innovation 🇪🇺@EUScienceInnov

On #AdaLovelaceDay we celebrate women in STEM 🎊 And today we highlight the great contribution of Prof. @annemariamay of @PREFERABLE_II to this field. See how the project helps improve cancer patients’ & survivors’ QoL 👉 t.ly/i1-TW #BreastCancerAwarenessMonth

English
0
4
13
1K
PREFERABLE_II
PREFERABLE_II@PREFERABLE_II·
Nice to meet the @MyPath_EU colleagues in Edinburgh and discuss their project. MyPath is led by @KaasaStein and Marie Fallon👇. MyPath aims to implement patient-centred care pathways in a digital solution for patients with cancer. Working together in the #QoL_Cluster @EU_HaDEA
PREFERABLE_II tweet media
English
0
1
7
250
PREFERABLE_II
PREFERABLE_II@PREFERABLE_II·
The PREFERABLE-II consortium met in Hannover 7-8 Sept. We are now finalizing the protocol for the clinical trial (LION-RCT), survey and focus groups (LION-COM and ELSI). Also legal and ethical aspects of live-remote training were discussed. #HorizonEU
PREFERABLE_II tweet media
English
0
5
15
1.4K
PREFERABLE_II retweetledi
Kathi Apostolidis
Kathi Apostolidis@kgapo·
Congratulations to the @PREFERABLE_II team for the great work recognised at the #EUOpenDay! The importance of #physicalactivity for #cancerpatients and #survivors was highlighted this week at the Annual Congress of FAVO @favo_it an ECPC @cancereu member #EUHealthResearch #HADEA
PREFERABLE_II@PREFERABLE_II

The PREFERABLE II project was showcased during the #EUOpenDay! We informed many visitors about the project and measured their handgrip strength, which we often do with pts in our exercise-oncology trials to evaluate exercise effects. #EUCancerMission #EUHealthResearch @EU_HaDEA

English
1
3
7
420
PREFERABLE_II
PREFERABLE_II@PREFERABLE_II·
The PREFERABLE II project was showcased during the #EUOpenDay! We informed many visitors about the project and measured their handgrip strength, which we often do with pts in our exercise-oncology trials to evaluate exercise effects. #EUCancerMission #EUHealthResearch @EU_HaDEA
PREFERABLE_II tweet media
English
0
2
9
1.1K